Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Spectrum Pharma Inc
(NQ:
SPPI
)
1.030
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Spectrum Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI
August 12, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
July 29, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
June 02, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
May 26, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
May 17, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 12, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer
May 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update
May 06, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors
May 05, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
April 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting
April 04, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer
March 24, 2022
Palm Beach, FL – March 24, 2022 – FinancialNewsMedia.com News Commentary – The status of breast cancer as one of the most commonly occurring cancers in the world is expected to be a key driving factor...
Via
FinancialNewsMedia
Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update
March 17, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting
February 28, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Alert: Update in Lawsuit
February 15, 2022
San Diego, CA -- (SBWIRE) -- 02/15/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors, who purchased shares of Spectrum Pharmaceuticals, Inc....
Via
SBWire
Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
February 11, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
January 20, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Announces Strategic Restructuring
January 05, 2022
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
January 04, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
December 06, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
December 01, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit
November 30, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Long Term Investor Alert: Investigation of Potential Wrongdoing
November 17, 2021
San Diego, CA -- (SBWIRE) -- 11/17/2021 -- An investigation on behalf of current long-term investors in shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) concerning potential breaches of fiduciary...
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
November 11, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update
November 10, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021
From
Spectrum Pharmaceuticals
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders
November 03, 2021
From
Robbins LLP
Via
Business Wire
FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
November 01, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
CLASS ACTION UPDATE for SPPI, APPH and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 01, 2021
NEW YORK, NY / ACCESSWIRE / November 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....
From
Levi & Korsinsky, LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.